Monogram Orthopaedics, Inc. (MGRM) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for MGRM is $5.40, representing a -10.0% downside from the current price of $6. Price targets range from a low of $5.40 to a high of $5.40.
